Orthofix Medical Inc. announced preliminary unaudited sales results for the fourth quarter and full year ended December 31, 2023. For the quarter, the company reported net sales of approximately $200.3 million, an increase of 63.8% on a reported basis and 62.8% on a constant currency basis versus fourth quarter 2022.

For the full year 2023, preliminary unaudited net sales were approximately $746.5 million, an increase of 62.0% on a reported basis and 61.5% on a constant currency basis.